Qlucore
Qlucore Gains CE-IVDR Certification for Pediatric Leukemia Testing Software
The firm's Qlucore Diagnostics 1.0 for BCP-ALL software is used to aid the diagnosis and treatment of B-cell precursor acute lymphoblastic leukemia.
The Swedish bioinformatics firm is targeting February 2025 for regulatory approval of its Qlucore Diagnostics software for transcriptomics-based ALL testing.
Qlucore Expands Into Bladder Cancer Diagnostics With Lund University Partnership
The company expects that this work to develop and validate classifier models for bladder cancer will lead to a CE mark for its Qlucore Diagnostics software platform.
Qlucore Teams With Semmelweis University on Pan-Cancer Classification
The Hungarian university will also use Qlucore's molecular diagnostics platform to improve diagnosis of acute lymphoblastic leukemia.
Jun 28, 2017